Arosi's successful launch and aggressive pricing from generic competition are impacting the pharmaceutical market.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Arosi's successful launch and aggressive pricing from generic competition are impacting the pharmaceutical market.
Keep exploring
Part of
The generic drug market is seeing significant growth, driven by Indian firms and regional markets, with major players like Aurobindo, J&J, and GSK involved.Also in this story
- BMY intended to expand manufacturing capacity in Europe and Japan, with Reuters reporting the decision.
- Sun Pharmaceutical Industries is identified as the largest drugmaker based in India.
- Indian drug makers are targeting the North American market.
Coverage
Newest first; wire copies grouped- GuruFocus.comJourney Medical Corp (DERM) Q2 2025 Earnings Call Highlights: Strong Arosi Launch Drives ... Release Date: August 12, 2025 For the complete transcript of the earnings call, please refer to the full e